Alpha Tau to Participate in May Investor Conferences

Provided By GlobeNewswire

Last update: May 6, 2025

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that CFO Raphi Levy will presentation in the following investor conferences in May 2025.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (5/30/2025, 8:00:01 PM)

2.985

-0.02 (-0.5%)

DRTS Overview

DRTS Technical Analysis Report

DRTS Fundamental Analysis Report

ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (5/30/2025, 8:00:01 PM)

0.21

-0.04 (-16%)